Health Canada Approves Arjuna's Shoden® Ashwagandha Extract as Natural Health Product
Key Insights
Health Canada has granted Natural Health Product status to Arjuna Natural (search)'s Shoden (search)® ashwagandha extract, validating its safety and efficacy claims for stress (search) reduction and sleep improvement.
The highly bioactive extract is standardized to contain over 35% withanolide glycosides (search) and has demonstrated clinical efficacy at low doses (60-120mg), supported by 11 clinical studies and 23 patents.
This regulatory approval enables Arjuna to make authorized health claims in Canada and potentially accelerate market expansion in the US, Europe, and Asia where Health Canada certification is highly regarded.
Nutraceutical company Arjuna Natural (search) Pvt. Ltd. has announced that its proprietary Shoden (search)® ashwagandha extract has received approval as a Natural Health Product (NHP) by Health Canada, marking a significant regulatory milestone for the company's flagship adaptogenic supplement.
The approval follows a rigorous pre-market review process that evaluated the extract's purity, potency, and scientific evidence supporting its efficacy. Health Canada's endorsement is widely recognized as a gold standard in natural health product certification globally.
Scientifically Advanced Ashwagandha Formulation
Shoden (search)® distinguishes itself in the crowded ashwagandha market through its standardization to more than 35% withanolide glycosides (search)—the key bioactive compounds responsible for the adaptogenic properties of Withania somnifera (ashwagandha). This standardization is verified using High-Performance Liquid Chromatography (HPLC) methodology.
"Our potent ashwagandha extract of the whole plant is derived from carefully chosen and validated sources using a proprietary extraction process," explains Dr. Benny Antony, Joint Managing Director for Arjuna Natural (search). "This ensures exceptional absorption and maximum utilization of the full spectrum of withanolide compounds, even at an unusually low dose of 60-120mg."
The extract's formulation is protected by 23 patents covering its unique composition and manufacturing methods, reflecting significant R&D investment in developing a differentiated product in the botanical extract space.
Validated Health Claims
The Health Canada approval authorizes Arjuna to make specific health claims for Shoden (search)®, including:
- Improved sleep onset, duration, and quality with continued use
- Increased resistance to stress and reduced symptoms of mild anxiety in individuals with chronic stress
- Reduced symptoms of stress over time
- Adaptogenic properties that increase energy and stress resistance
- Support for healthy testosterone production in males
- Reduction of cortisol, a biomarker of physical stress
These claims are supported by substantial clinical evidence, with Dr. Antony noting that the regulatory recognition addresses a significant market issue: "Troublingly, there are numerous unregulated ashwagandha extracts on the market that are failing to deliver what they promise."
Robust Clinical Evidence
The scientific foundation for Shoden (search)® includes 11 clinical studies and 4 animal studies demonstrating its efficacy in stress (search) reduction, anxiety (search) alleviation, and sleep improvement—even at relatively low doses compared to conventional ashwagandha supplements.
Research has identified specific mechanisms of action, including regulation of the hypothalamus-pituitary-adrenal axis (search), reduction of cortisol levels, and increased GABA neurotransmitter activity, which contributes to its relaxation effects.
Additional studies have revealed immunomodulatory benefits, with improvements in immune cell markers including natural killer and T-cell activity, suggesting potential applications for immune support.
Pharmacokinetic evaluations have confirmed exceptional bioavailability of the withanolides in Shoden (search)®, while toxicity studies have established a strong safety profile for the extract.
Market Implications
The Health Canada approval has significant commercial implications for Arjuna Natural (search), potentially accelerating the extract's adoption in multiple markets.
"The US, and countries in Europe and Asia view Health Canada approval as a highly reliable benchmark for quality, which will fast-track Shoden (search)®'s expansion into those markets," notes Dr. Antony.
The approval also benefits supplement manufacturers who can now include specific health claims related to Shoden (search)® on their product labels when using the extract as an ingredient.
Versatile Applications
Shoden (search)® is currently available in three dosage strengths and multiple supplement formats, including pills, capsules, and powders. The extract's efficacy at low doses (60-120mg) makes it particularly suitable for incorporation into functional foods and beverages, including soft drinks, energy shots, and sports nutrition products—a growing segment of the nutraceutical market.
This versatility positions Shoden (search)® to capitalize on the increasing consumer demand for adaptogenic ingredients with stress (search)-reduction and sleep-improvement benefits, particularly as mental wellbeing becomes a greater focus in the health supplements industry.
Company Background
Arjuna Natural (search) has established itself as India's leading manufacturer of standardized spice and botanical extracts for over 25 years. Founded in 1989, the company serves customers in 70 countries and maintains advanced research facilities that collaborate with international universities on phytochemistry, pharmacokinetics, formulation development, and pre-clinical research.
The company's manufacturing facilities comply with international standards and hold multiple certifications, including GMP, ISO, NSF, Star-K kosher, and halal certification, reflecting its commitment to quality and regulatory compliance across global markets.